Martin Haluzı́k

Institute of Clinical and Experimental Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Dapagliflozin, peptide YY, and weight loss in heart failure with preserved ejection fraction”.

Dapagliflozin, peptide YY, and weight loss in heart failure with preserved ejection fraction

European Heart Journal(2024)10.1093/eurheartj/ehae534

N/A

0DataRank · unranked

16 citations

Vojtěch Melenovský, Aneesh K Asokan, Martin Haluzı́k, Rickey E. Carter, K. Sreekumaran Nair +3 more

Risk Stratification and Coronary Optical Coherence Tomography Findings in Asymptomatic Patients With Type 1 Diabetes Mellitus

Physiological Research(2025)10.33549/physiolres.935614

N/A

0DataRank · unranked

0 citations

Michal Dubský, Peter Wohlfahrt, NATÁLIA MARHEFKOVÁ, Zhi Chen, Milan Sonka +5 more